-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: June 2011
Competition gets fierce for innovative science
From FierceBiotech At the height of recession, biotechs were hurting for cash. Big Pharma and its deep pockets were there to cherry-pick the best science at an affordable price from small companies that had little choice but to make deals. But the balance of power has shifted in the past year. Pharma is now face-to-face with the patent cliff, and hardly a week goes by without mention of the industry’s unproductive, yet very costly, R&D Read More >
FierceBiotech providing live coverage of the 2011 BIO International Convention
FierceBiotech is reporting live from the annual BIO International Convention in Washington, D.C., this week. Check our our BIO 2011 microsite to keep up with news, events and tweets from the show. And if you haven’t already, register now for FierceBiotech’s executive breakfast tomorrow. We’ll examine the issues facing today’s drug developers as they navigate the challenges involved in obtaining FDA approval. Read more from John’s blog (one of our official bloggers): Live from BIO: Read More >
Innovate the Four ‘D’s When Pushing Forward Vaccine Development
The vaccine market is surging. From next-generation illness fighters in developed countries to treatment vaccines that combat infectious diseases throughout emerging regions, technological advances in this space and strategies to develop better existing vaccines as well as new products are in high demand. Seasoned vaccine experts speaking at a vaccines panel session at the 2011 BIO International Convention shared with attendees a significant golden rule to follow: In order to ensure success, innovation is required Read More >
Profiling Cuban Biotechnology
Yali Friedman, BIO Official Blogger from the BIOtechBlog, will be giving a brief talk on the Cuban Biotechnology industry during a panel at the 2011 BIO International Convention today. What: Cuban Biotechnology: An Overview of Cuba’s Drug and Vaccine Developments and Innovations When: 2:00 – 2:45pm Where: Room 145B Who: Elaine Scheye, Yali Friedman, Halla Thortsteinsdottir, Pedro Freyre I will be largely citing papers published in the Journal of Commercial Biotechnology and providing a brief overview and Read More >
Diversity Summit Reveals Ways Biotech Can Better Integrate Diverse Populations
Dr. Augustus White, III, author of Seeing Patients: Unconscious Bias in Health Care and a pioneer in equitable care delivered the keynote address at this year’s Diversity Summit at the 2011 BIO International Convention in Washington, D.C. The Summit brought together an esteemed panel of speakers to discuss integrating diverse and underserved populations with the medical, agricultural, and energy research industries. Panelists included Freda C. Lewis-Hall, M.D., Executive Vice President and Chief Medical Officer at Read More >
